Related Experiment Video
Updated: Jun 27, 2026
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Molecular analysis of gene expression in tumor pathology
Heinz Höfler1, Katja Specht, Karl-Friedrich Becker
1Institut für Pathologie, Technische Universität München, Germany. hoefler@lrz.tum.de
Abstract:
Human cancers are diverse in their pathology and responsiveness to clinical treatment. This diversity is at least in part due to variations in cellular gene expression programs. Although the analyis of proteins--the key players in cells and potential drug targets--is advancing rapidly, there are situations in which the analysis of RNA rather than proteins can provide valuable information for the diagnosis of cancer. These situations include absense of an antibody for the protein of interest, expression of functionally defective proteins, expressed small nucleotide polymorphisms (SNPs), analysis of alternatively or abnormally spliced molecules, and functional analysis of splice site mutations. In this chapter we will focus on the analysis of RNA from clinical samples and will summarize how gene expression studies on the RNA level using a variety of new tools can be useful for discovering new classes of tumors, for predicting clinical outcome or therapy response, and for designing novel personalized clinical interventions that can not be achieved with histology alone.
Insights
Analyzing RNA from clinical samples offers valuable insights into cancer diversity, aiding in tumor classification, predicting patient outcomes, and personalizing treatments beyond traditional histology.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Human cancers exhibit significant diversity in pathology and treatment response, partly due to variations in cellular gene expression.
- While protein analysis is advancing, RNA analysis provides crucial information when proteins are difficult to study or present with specific alterations.
Purpose of the Study:
- To highlight the utility of RNA analysis from clinical samples for cancer diagnosis and personalized medicine.
- To demonstrate how gene expression studies at the RNA level can complement or surpass traditional histological methods.
Main Methods:
- Focus on the analysis of RNA extracted from clinical samples.
- Utilizes a variety of new gene expression analysis tools.
- Explores applications in tumor classification, outcome prediction, and therapeutic strategy design.
Main Results:
- RNA analysis can provide valuable diagnostic information in specific scenarios, such as the absence of protein antibodies or the presence of specific genetic variations.
- Gene expression studies on the RNA level can identify new tumor classes.
- RNA-level analysis aids in predicting clinical outcomes and therapy response.
Conclusions:
- RNA analysis offers a powerful approach to understanding cancer heterogeneity and improving patient care.
- Gene expression profiling at the RNA level enables personalized clinical interventions not achievable through histology alone.
- This approach enhances the potential for discovering novel diagnostic and prognostic markers in oncology.
